Repligen (RGEN) Change in Acquisitions & Divestments (2010 - 2026)

Repligen's (RGEN) quarterly Change in Acquisitions & Divestments came in at $66.0 million in Q1 2026, up 2300.0% on a QoQ basis from $2.8 million in Q3 2017.

Repligen (RGEN) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Repligen (RGEN) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $66.0 million in Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $66.0 million in Q1 2026; TTM through Mar 2026 was $66.0 million, a N/A change from a year earlier, with the FY2023 full-year figure at $102.3 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 stood at $66.0 million, up from $2.8 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for RGEN reached as high as $66.0 million in Q1 2026 and fell as low as $66.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 126.58 Bn 121.36 Bn 1.96 Bn
2 Becton Dickinson 44.90 Bn 44.08 Bn 2.15 Bn
3 Alcon 32.95 Bn 31.29 Bn 1.53 Bn
4 Medline 32.83 Bn 30.59 Bn 1.84 Bn
5 Resmed 29.38 Bn 27.72 Bn 890.98 Mn
6 West Pharmaceutical Services 23.41 Bn 22.98 Bn 329.20 Mn
7 Solventum 14.08 Bn 13.52 Bn 1.10 Bn
8 Cooper Companies 13.79 Bn 13.66 Bn 735.40 Mn
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn
10 Repligen 7.41 Bn 6.42 Bn 108.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 66.00 Mn
Mar 31, 2026 66.00 Mn
Sep 30, 2017 2.75 Mn
Sep 30, 2017 2.75 Mn
Jun 30, 2017 9.45 Mn
Jun 30, 2017 9.45 Mn
Mar 31, 2017 7.40 Mn
Mar 31, 2017 7.40 Mn
Dec 31, 2016 3.70 Mn
Dec 31, 2016 3.70 Mn
Sep 30, 2016 5.60 Mn
Sep 30, 2016 5.60 Mn
Jun 30, 2016 8.50 Mn
Jun 30, 2016 8.50 Mn
Mar 31, 2016 5.60 Mn
Mar 31, 2016 5.60 Mn
Dec 31, 2015 9.32 Mn
Dec 31, 2015 9.32 Mn
Sep 30, 2015 7.91 Mn
Sep 30, 2015 7.91 Mn